Trial of Shaladi Churna in the management of Diabetes Mellitus

Randomized controlled trial of “shaladi churna ? as an add-on effect in the Management of madhumeha with special reference to diabetes mellitus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054215

Enrollment

Registered

2023-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group: between 30 years to 60 years. 2) Gender: Male and Female both will be included. 3) A known Diabetic on treatment and newly diagnosed Diabetes. 4) Patient with fasting blood sugar up to 220 mg/dl & post prandial blood sugar upto 300 mg/dl. 5) Patient having HbA1c in between 7 to 9 and Sr. Insulin.

Exclusion criteria

Exclusion criteria: 1) IDDM, Acromegaly, Cushing’s syndrome and pancreatic disorder. 2) Pregnant and lactating mothers. 3) Patients with K/C/O Nephropathy, Neuropathy and Retinopathy. 4) Patients with gastrointestinal diseases, Liver diseases, tumours, cardio vascular disease, acute myocardial infarction, immune-compromised disease(HIV).

Design outcomes

Primary

Measure	Time frame
Glycosylated hemoglobin Blood Sugar levels Timepoint: at baseline, 4 weeks, 8 weeks and 12 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Kalyani N Thote

MAMS Sumatibhai Shah Ayurved College Hdapsar Pune

kalyanithote7026@gmail.com

Outcome results